FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019809898> ?p ?o ?g. }

• W2019809898 endingPage "130" @default.
• W2019809898 startingPage "121" @default.
• W2019809898 abstract "Current guidelines for the initial treatment of bipolar type I (BP I) and bipolar type II (BP II) major depressive episode (MDE) recommend avoiding the use of antidepressant drugs due to concerns over drug-induced manic switch episodes. However, recent evidence suggests that the manic switch rate during SSRI therapy of BP MDE may be lower than previously thought. This preliminary, placebo-controlled study examines the relative rates of treatment-emergent manic symptoms during fluoxetine monotherapy, olanzapine monotherapy, and combined fluoxetine plus olanzapine therapy of BP I and BP II MDE. 32 BP I and 2 BP II MDE patients were randomized to receive double-blind therapy with fluoxetine monotherapy 10–30 mg daily, olanzapine monotherapy 5–20 mg daily, combined therapy with fluoxetine 10–40 mg plus olanzapine 5–15 mg daily, or placebo for up to 8 weeks. Outcome measures included the 17-item HAM-D, 17-item HAM-D “atypical” symptom profile (HAM-D 17-R), 28 item HAM-D, Montgomery–Asberg Depression Rating Scale (MADRS), and the Young Mania Rating (YMR) scale. There were significant reductions over time in mean HAM-D 28 and MADRS ratings for all treatment groups (p < 0.006). However, there were no differences among treatment conditions (p = ns). There was no significant increase in YMR scores over time in any treatment group. In contrast, there was a significant reduction in the mean YMR score in the fluoxetine-treated patients over time (p = 0.008). No patient met DSM IV criteria for a manic episode. Cohort sizes were limited and the study was not powered to detect statistical differences in efficacy or mania symptoms among treatment conditions. The dose of fluoxetine was modest and the treatment duration was limited to 8 weeks. These observations support earlier findings of a low manic switch rate during fluoxetine monotherapy of BP I and BP II MDE, and suggest that fluoxetine may be a safe initial treatment of BP MDE alone or in combination with olanzapine." @default.
• W2019809898 created "2016-06-24" @default.
• W2019809898 creator A5002520132 @default.
• W2019809898 creator A5046106672 @default.
• W2019809898 date "2005-07-01" @default.
• W2019809898 modified "2023-10-16" @default.
• W2019809898 title "Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression—lack of manic induction" @default.
• W2019809898 cites W12210335 @default.
• W2019809898 cites W1564187438 @default.
• W2019809898 cites W171831126 @default.
• W2019809898 cites W192481466 @default.
• W2019809898 cites W1969137852 @default.
• W2019809898 cites W1970891546 @default.
• W2019809898 cites W1979999703 @default.
• W2019809898 cites W1983164699 @default.
• W2019809898 cites W1993342677 @default.
• W2019809898 cites W1994759548 @default.
• W2019809898 cites W1998085422 @default.
• W2019809898 cites W1999389597 @default.
• W2019809898 cites W2016999205 @default.
• W2019809898 cites W2021627893 @default.
• W2019809898 cites W2026272713 @default.
• W2019809898 cites W2046422289 @default.
• W2019809898 cites W2058662910 @default.
• W2019809898 cites W2069887098 @default.
• W2019809898 cites W2077250758 @default.
• W2019809898 cites W2077601259 @default.
• W2019809898 cites W2084686735 @default.
• W2019809898 cites W2085589409 @default.
• W2019809898 cites W2097417981 @default.
• W2019809898 cites W2103553382 @default.
• W2019809898 cites W2109973761 @default.
• W2019809898 cites W2111355579 @default.
• W2019809898 cites W2114613490 @default.
• W2019809898 cites W2117305486 @default.
• W2019809898 cites W2124509426 @default.
• W2019809898 cites W2124907633 @default.
• W2019809898 cites W2130261986 @default.
• W2019809898 cites W2131823335 @default.
• W2019809898 cites W2149231151 @default.
• W2019809898 cites W2153284906 @default.
• W2019809898 cites W2167659819 @default.
• W2019809898 cites W2317383367 @default.
• W2019809898 cites W2343481880 @default.
• W2019809898 cites W4233714330 @default.
• W2019809898 cites W4255578794 @default.
• W2019809898 cites W653308154 @default.
• W2019809898 doi "https://doi.org/10.1016/j.jad.2005.02.018" @default.
• W2019809898 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15923042" @default.
• W2019809898 hasPublicationYear "2005" @default.
• W2019809898 type Work @default.
• W2019809898 sameAs 2019809898 @default.
• W2019809898 citedByCount "80" @default.
• W2019809898 countsByYear W20198098982012 @default.
• W2019809898 countsByYear W20198098982013 @default.
• W2019809898 countsByYear W20198098982014 @default.
• W2019809898 countsByYear W20198098982015 @default.
• W2019809898 countsByYear W20198098982016 @default.
• W2019809898 countsByYear W20198098982017 @default.
• W2019809898 countsByYear W20198098982018 @default.
• W2019809898 countsByYear W20198098982019 @default.
• W2019809898 countsByYear W20198098982020 @default.
• W2019809898 countsByYear W20198098982021 @default.
• W2019809898 countsByYear W20198098982022 @default.
• W2019809898 countsByYear W20198098982023 @default.
• W2019809898 crossrefType "journal-article" @default.
• W2019809898 hasAuthorship W2019809898A5002520132 @default.
• W2019809898 hasAuthorship W2019809898A5046106672 @default.
• W2019809898 hasConcept C118552586 @default.
• W2019809898 hasConcept C126322002 @default.
• W2019809898 hasConcept C142724271 @default.
• W2019809898 hasConcept C15744967 @default.
• W2019809898 hasConcept C168563851 @default.
• W2019809898 hasConcept C170493617 @default.
• W2019809898 hasConcept C204787440 @default.
• W2019809898 hasConcept C27081682 @default.
• W2019809898 hasConcept C2775864247 @default.
• W2019809898 hasConcept C2776134451 @default.
• W2019809898 hasConcept C2776174506 @default.
• W2019809898 hasConcept C2776412080 @default.
• W2019809898 hasConcept C2776466505 @default.
• W2019809898 hasConcept C2776619155 @default.
• W2019809898 hasConcept C2776809841 @default.
• W2019809898 hasConcept C2777089681 @default.
• W2019809898 hasConcept C2778541603 @default.
• W2019809898 hasConcept C2779177272 @default.
• W2019809898 hasConcept C2780051608 @default.
• W2019809898 hasConcept C2780733359 @default.
• W2019809898 hasConcept C558461103 @default.
• W2019809898 hasConcept C71924100 @default.
• W2019809898 hasConceptScore W2019809898C118552586 @default.
• W2019809898 hasConceptScore W2019809898C126322002 @default.
• W2019809898 hasConceptScore W2019809898C142724271 @default.
• W2019809898 hasConceptScore W2019809898C15744967 @default.
• W2019809898 hasConceptScore W2019809898C168563851 @default.
• W2019809898 hasConceptScore W2019809898C170493617 @default.
• W2019809898 hasConceptScore W2019809898C204787440 @default.
• W2019809898 hasConceptScore W2019809898C27081682 @default.

• next